Compare IX & PHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IX | PHG |
|---|---|---|
| Founded | 1950 | 1891 |
| Country | Japan | Netherlands |
| Employees | N/A | N/A |
| Industry | Diversified Financial Services | Medical Electronics |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.6B | 26.8B |
| IPO Year | 1970 | N/A |
| Metric | IX | PHG |
|---|---|---|
| Price | $28.86 | $26.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 190.6K | ★ 679.6K |
| Earning Date | 11-12-2025 | 11-04-2025 |
| Dividend Yield | 2.62% | ★ 3.10% |
| EPS Growth | ★ 11.37 | N/A |
| EPS | ★ 2.62 | 0.21 |
| Revenue | $20,512,909,787.00 | ★ $20,861,199,111.00 |
| Revenue This Year | $8.93 | $0.72 |
| Revenue Next Year | $3.27 | $3.11 |
| P/E Ratio | ★ $10.79 | $131.46 |
| Revenue Growth | ★ 6.22 | N/A |
| 52 Week Low | $17.75 | $21.48 |
| 52 Week High | $29.33 | $29.54 |
| Indicator | IX | PHG |
|---|---|---|
| Relative Strength Index (RSI) | 66.78 | 44.41 |
| Support Level | $28.39 | $26.12 |
| Resistance Level | $29.08 | $27.17 |
| Average True Range (ATR) | 0.29 | 0.29 |
| MACD | 0.03 | -0.05 |
| Stochastic Oscillator | 77.29 | 28.64 |
ORIX Corp is a diversified financial services company with operations in Corporate Financial Services, Maintenance Leasing, Real Estate, PE Investment and Concession, Environment and Energy, Insurance, Banking and Credit, Aircraft and Ships, ORIX USA, ORIX Europe, Asia, and Australia and engages in various other fee businesses by providing products and services aligned with customer needs to its core customer base of domestic small and medium-sized enterprises. Orix's numerous divisions finance leases of large-ticket items like ships, airplanes, and technology equipment. The company generates the majority of its revenue from Corporate Financial Services and Maintenance Leasing operations and Real Estate operations.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.